Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours. That makes two quarters in a row. Morgan Stanley beat Wall Street estimates for second quarter earnings on Wednesday, following the trend set by its peers. Each of the key business lines at the bank posted increased revenues, with revenues more broadly holding remarkably steady. In particular, the bank posted only a small drop in fixed income trading revenues, dropping 4% year-on-year to $1.24 billion. Given a sharp decline in fixed income revenues at rival Goldman Sachs, where revenues fell 40% to $1.16 billion, the results mean that Morgan Stanley bested Goldman Sachs in fixed income for the second quarter in a row. Baupost Group, a $30 billion hedge fund, has laid out a road map for market chaos. In a second quarterly private letter that was reviewed by Business Insider, Baupost said that the problem lies with a signature feature of current markets: low volatility. "Structural leverage linked to low realized volatility may well prove destabilizing and the precipitant, or at least an accelerant for the next financial crisis," the letter said. A hedge fund started by Steve Cohen's former chief operating officer might be turning itself around. Betterment has taken its first step into one of the hottest areas of investing. And the head of Yale's $26 billion endowment is calling out Wall Street. Here's the inside story on the decades-long quest to bring down financial information giant Bloomberg. Jeff Gundlach trolled Chipotle after its latest food scare. Traders betting against Chipotle have been doing it all wrong. And here's the best way to trade the market's hottest stocks. McCormick & Co is buying the food business of British consumer goods conglomerate Reckitt Benckiser for $4.2 billion. BP is thinking about an IPO for its US pipeline assets. Blue Apron's IPO is a big flop — here's how it compares to other popular startups. And here's what it's like behind the scenes at QVC — the retail powerhouse that plans to buy rival HSN for $2.1 billion. And here's how the CEO of a $50 billion drugmaker sees tech companies "disrupting" healthcare. Lastly, here are 21 of the world's most beautiful restaurants. |
Tidak ada komentar:
Posting Komentar